Afluria Pregnancy Registry
A Prospective Observational Safety Study on Pregnancy Outcomes in Women Immunized With Afluria, a Seasonal Influenza Vaccine, During Pregnancy
Sponsor: Seqirus
A observational or N/A phase clinical study on Birth Defect and Influenza, Human, this trial is completed. The trial is conducted by Seqirus and has accumulated 11 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Mar 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2021 — Mar 2022 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
May 2021 — Sep 2021 [monthly]
Recruiting
▶ Show 6 earlier versions
-
Apr 2021 — May 2021 [monthly]
Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Recruiting
-
May 2019 — Jan 2021 [monthly]
Recruiting
-
Jun 2018 — May 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Recruiting NA
First recorded
Sep 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Seqirus
For direct contact, visit the study record on ClinicalTrials.gov .